Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Shashank Sinha

Advanced Heart Failure · Inova Fairfax Hospital

View

Dr. Javed Butler

Advanced Heart Failure · Baylor Health Care System

View

Dr. Andrew Sauer

Advanced Heart Failure · Saint Luke's

View

Dr. Anu Lala

Advanced Heart Failure · Mount Sinai

View

Dr. Robert Mentz

Advanced Heart Failure · Duke University

View

Dr. Sunny Varshney

Advanced Heart Failure · Stanford

View

Dr. Stephanie Hsiao

Advanced Heart Failure · Stanford

View

Dr. Michelle Kittleson

Advanced Heart Failure · Cedars-Sinai

View

Dr. Adrian Hernandez

Advanced Heart Failure · Duke

View

Dr. Dorairaj Prabhakaran

General Cardiology

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    NSDr. Nitasha Sarswat

    Dr. Nitasha Sarswat

    Cardiology · Advanced Heart Failure & Transplantation
    University of Chicago Medical Center
    nitasha

    Research

    Clinical Features of Systemic Amyloidosis: A Scoping Review

    2026

    Via Blood Advances

    Research

    Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension

    2026

    Via JAMA Cardiology

    Research

    Alternative Measures of Body Composition and Outcomes Following Heart Transplant

    2026

    Via Clinical Transplantation

    Research

    Acoramidis in Transthyretin Amyloid Cardiomyopathy: Expanding Evidence from ATTRibute-CM

    2026

    Via Future Cardiology

    Research

    The Role of Cardiac Imaging for Diagnosis of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis of Test Accuracy

    2026

    Via Amyloid: The International Journal of Experimental and Clinical Investigation

    Research

    Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial

    2026

    Via JAMA Cardiology

    May 1, 2026Journal Article

    Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial.

    ​

    Written by 1 Roon author & 22 others

    Via Journal of Cardiac Failure
    May 27, 2026Journal Article

    Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

    ​

    Written by 1 Roon author & 29 others

    Via The American Heart Association Journals

    Research

    Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis

    2026

    Via European Heart Journal. Cardiovascular Imaging

    Research

    American Society of Hematology 2026 guidelines on diagnosis of light chain amyloidosis

    2026

    Via Blood Advances

    Research

    Age-Adjusted Echocardiographic Parameters for Differentiating Cardiac Amyloidosis and Hypertrophic Cardiomyopathy

    2025

    Via Journal of the American Society of Echocardiography

    Research

    Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy

    2025

    Via Journal of the American College of Cardiology

    Research

    Disparities in Diagnosis and Outcomes in American Patients with Transthyretin Cardiac Amyloidosis

    2025

    Via The International Journal of Cardiovascular Imaging

    Research

    Cardiac Amyloidosis Detection from a Single Echocardiographic Video Clip: A Novel Artificial Intelligence-Based Screening Tool

    2025

    Via European Heart Journal

    Feb 13, 2025Journal Article

    Mitigating Post-operative Right Ventricular Dysfunction After Left Ventricular Assist Device: The RV Protection Study.

    ​
    ​

    Written by 2 Roon authors & 19 others

    Via Journal of Cardiac Failure